BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27226509)

  • 1. Metastatic Colorectal Cancer: Lessons Learned, Future Possibilities.
    Venook AP
    J Natl Compr Canc Netw; 2016 May; 14(5 Suppl):666-8. PubMed ID: 27226509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopy for metastatic colorectal cancer.
    Champagne BJ; Delaney CP
    Surg Oncol; 2007 Jul; 16(1):15-24. PubMed ID: 17548191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biological, and molecular aspects of metastasis in colorectal cancer.
    Stein U; Schlag PM
    Recent Results Cancer Res; 2007; 176():61-80. PubMed ID: 17607917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.
    Del Rio M; Mollevi C; Bibeau F; Vie N; Selves J; Emile JF; Roger P; Gongora C; Robert J; Tubiana-Mathieu N; Ychou M; Martineau P
    Eur J Cancer; 2017 May; 76():68-75. PubMed ID: 28284171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer. Clinical and pathologic features.
    Gore RM
    Radiol Clin North Am; 1997 Mar; 35(2):403-29. PubMed ID: 9087211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel agents in the treatment of metastatic colorectal cancer.
    Leong S; Messersmith WA; Tan AC; Eckhardt SG
    Cancer J; 2010; 16(3):273-82. PubMed ID: 20526106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the Primary Tumor in Stage IV Colorectal Cancer: When Is It Necessary?
    Feo L; Polcino M; Nash GM
    Surg Clin North Am; 2017 Jun; 97(3):657-669. PubMed ID: 28501253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic colorectal cancer: recent advances in its clinical management.
    Barugel ME; Vargas C; Krygier Waltier G
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1829-47. PubMed ID: 19954294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
    Holen KD; Saltz LB
    Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of metastatic colorectal cancer].
    Tournigand C; Bengrine-Lefevre L; Chibaudel B; de Gramont A
    Rev Prat; 2010 Oct; 60(8):1103-7. PubMed ID: 21197743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line treatment strategies for elderly patients with metastatic colorectal cancer.
    Meulenbeld HJ; Creemers GJ
    Drugs Aging; 2007; 24(3):223-38. PubMed ID: 17362050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-line therapy for metastatic colorectal cancer.
    Gundgaard MG; Soerensen JB; Ehrnrooth E
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer.
    Weinberg BA; Marshall JL; Salem ME
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):630-8. PubMed ID: 27487107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment of metastatic colorectal cancer.
    Pessino A; Sobrero A
    Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cross-sectional imaging of colorectal cancer.
    Schwartz LH
    Semin Oncol; 1999 Oct; 26(5):569-76. PubMed ID: 10528906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -8p12-23 and +20q are predictors of subtypes and metastatic pathways in colorectal cancer: construction of tree models using comparative genomic hybridization data.
    Li X; Chen J; Lü B; Peng S; Desper R; Lai M
    OMICS; 2011; 15(1-2):37-47. PubMed ID: 21194300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives.
    Geng F; Wang Z; Yin H; Yu J; Cao B
    Cancer Biother Radiopharm; 2017 Jun; 32(5):149-160. PubMed ID: 28622036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
    Saltz LB; Douillard JY; Pirotta N; Alakl M; Gruia G; Awad L; Elfring GL; Locker PK; Miller LL
    Oncologist; 2001; 6(1):81-91. PubMed ID: 11161231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
    Atreya CE; Yaeger R; Chu E
    Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.